Cataract Awareness Month: A Healthy Ocular Surface Is Part of a Good Outcome

Cataract surgery is one of the most common and successful procedures in medicine, and Cataract Awareness Month is a good moment to highlight a step that quietly shapes how well it goes: the health of the ocular surface. The front of the eye is its first optical element, and both the planning of surgery and the comfort that follows depend on a stable, well-lubricated surface. Caring for it before and after the operation helps patients reach the clear, comfortable vision the surgery is meant to deliver.

Why the surface matters before surgery

Choosing the right intraocular lens depends on precise biometry and corneal measurements. When the tear film is unstable, the surface being measured changes between blinks, and that introduces error into the readings used to plan the procedure. Optimising the surface first produces more reliable measurements and therefore better surgical planning. This matters even for patients who feel fine: TFOS DEWS III explicitly recognises a group with signs of ocular surface disturbance without yet noticing symptoms, and people scheduled for cataract surgery are a prime example (TFOS DEWS III, 2025, American Journal of Ophthalmology).

Why symptoms can appear afterward

Surgery can temporarily disturb the surface. Incisions may interrupt some of the corneal nerves that signal the eye to produce tears and blink, and the procedure and its medications can provoke inflammation and destabilise the tear film. Patients who already had subclinical meibomian gland dysfunction or dry eye are the most likely to notice dryness, grittiness, burning or fluctuating vision afterward. These symptoms usually improve as the eye heals, but anticipating and supporting the surface eases the course and protects the visual result.

Where light-based therapy fits

Espansione's platform sits upstream and downstream of the operation without disrupting the surgical workflow. LM™ LLLT photobiomodulation supports meibomian gland function and calms inflammation, and the professional meibomask® is positioned specifically for surgeons preparing the ocular surface, with eye-light® covering the same anterior-segment protocols.

Randomised, sham-controlled evidence now supports treating in the perioperative window. Around cataract surgery, perioperative LM™ LLLT helped preserve tear volume and comfort where untreated eyes declined (Giannaccare et al., 2024, British Journal of Ophthalmology). A parallel trial in Femto-LASIK found that light therapy given before and after surgery preserved tear meniscus height, tear production and patient-reported comfort through three months while the sham group declined, although tear-film breakup time did not differ significantly between groups (Solarino et al., 2026, Therapeutic Advances in Ophthalmology). Timing and suitability are always decided by the operating surgeon, and treatments are used within their cleared indications. For more detail, see ocular surface optimisation before surgery and supporting the surface after surgery.

The takeaway for Cataract Awareness Month

A healthy ocular surface is not a side issue in cataract care. It supports the accuracy of the measurements that guide lens choice and the comfort that defines how the result feels to the patient. Raising awareness of that, and addressing the surface early, is one of the most practical ways to help an already excellent operation deliver its best.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.